AMIA Joins Alliance for Connected Care on Telemedicine Access Reform

AMIA joined with over 200 organizations, submitted a joint letter urging the DEA to finalize regulations for a special registration process that would permit telemedicine prescribing of controlled substances without requiring in-person visits. The letter emphasizes that delays in finalizing these rules jeopardize access to care for patients relying on telehealth for treatment, especially for mental health, substance use disorders, and other chronic conditions. The signatories—ranging from healthcare systems and professional associations to patient advocacy groups—stress that a clear, permanent pathway for telemedicine prescribing is essential to maintaining continuity of care and addressing ongoing public health and equity challenges.